TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

Author： Bjerre Christina   Vinther Lena   Belling Kirstine   Würtz Sidse   Yadav Rachita   Lademann Ulrik   Rigina Olga   Do Khoa   Ditzel Henrik   Lykkesfeldt Anne   Wang Jun   Nielsen Henrik   Brünner Nils   Gupta Ramneek   Schrohl Anne-Sofie   Stenvang Jan  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.34, Iss.6, 2013-12, pp. : 3839-3851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Activation of Tolllike receptor 7 regulates the expression of IFNλ1, p53, PTEN, VEGF, TIMP1 and MMP9 in pancreatic cancer cells

By                

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1807-1812

Spandidos Publications

Access to resources Recommend Favorite

Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells

By Smolnikar K.   Löffek S.   Schulz T.   Michna H.   Diel P.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 3, 2000-10 ,pp. : 249-259

Springer Publishing Company

Access to resources Recommend Favorite

Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53

By Wang J. A.   Fan S.   Yuan R. Q.   X. Y.   Meng Q.   Goldberg I. D.   Rosen E. M.  

International Journal of Radiation Biology, Vol. 75, Iss. 3, 1999-03 ,pp. : 301-316

Informa Healthcare

Access to resources Recommend Favorite

Protein Oglucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells

By            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 594-600

Spandidos Publications

Access to resources Recommend Favorite

Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin

By                

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1481-1486

Spandidos Publications

Access to resources Recommend Favorite